L1CAM and endometrial cancer: In this comprehensive analysis of 648 high-risk EC, we evaluated the prognostic value of ER, PR, L1CAM and CTNNB1 mutations and established clinicopathologic and molecular risk factors in one of the largest cohorts of molecularly classified high-risk endometrial cancers worldwide.